Aman P. Singh

1.0k total citations
33 papers, 749 citations indexed

About

Aman P. Singh is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Aman P. Singh has authored 33 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in Aman P. Singh's work include Monoclonal and Polyclonal Antibodies Research (11 papers), CAR-T cell therapy research (10 papers) and HER2/EGFR in Cancer Research (8 papers). Aman P. Singh is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), CAR-T cell therapy research (10 papers) and HER2/EGFR in Cancer Research (8 papers). Aman P. Singh collaborates with scholars based in United States, Japan and India. Aman P. Singh's co-authors include Dhaval K. Shah, Sharad Sharma, Donald Heald, Xirong Zheng, Weirong Wang, Thomas Carpenter, Ashwni Verma, Gloria Wong, Leiming Guo and Young G. Shin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and European Heart Journal.

In The Last Decade

Aman P. Singh

26 papers receiving 710 citations

Peers

Countries citing papers authored by Aman P. Singh

Since Specialization

Citations

This map shows the geographic impact of Aman P. Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aman P. Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aman P. Singh more than expected).

Fields of papers citing papers by Aman P. Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aman P. Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aman P. Singh. The network helps show where Aman P. Singh may publish in the future.

Co-authorship network of co-authors of Aman P. Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Aman P. Singh. A scholar is included among the top collaborators of Aman P. Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aman P. Singh. Aman P. Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of preoperative nutritional status on 30-day outcomes after elective lumbar laminectomy for lumbar stenosis: a population-based cohort analysis 2025 ·Asian Spine Journal ·(unknown), Aman P. Singh, Prasanth Romiyo, (unknown)	0
2	Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia 2025 ·Vaccines ·Suresh Giri, Akshyaya Rath, Chitrang Trivedi, (unknown), (unknown), (unknown), (unknown), Aman P. Singh, Chintan Patel, (unknown), (unknown), (unknown), (unknown), (unknown), Rajesh Bahekar, (unknown), (unknown), (unknown), Mukul R. Jain	0
3	Mechanistic Evaluation of Anti‐CD19 CAR‐T Cell Therapy Repurposed in Systemic Lupus Erythematosus Using a Quantitative Systems Pharmacology Model 2025 ·Clinical and Translational Science ·(unknown), (unknown), Aman P. Singh	2
4	Comparing short term clinical outcomes of elective robot-assisted vs. non-robot assisted posterior lumbar interbody fusions: a NSQIP analysis 2025 ·Journal of Neurosurgical Sciences ·(unknown), Aman P. Singh, Prasanth Romiyo, Jonathan J. Stone, (unknown)	0
5	Translational PK–PD model for in vivo CAR‐T‐cell therapy delivered using CAR mRNA‐loaded polymeric nanoparticle vector 2024 ·Clinical and Translational Science ·(unknown), (unknown), Aman P. Singh	3
6	Double Crush Syndrome in the Lower Extremity: Simultaneous L5 Radiculopathy and Common Peroneal Nerve Compression 2024 ·World Neurosurgery ·Gabrielle Santangelo, Aman P. Singh, (unknown), Kitty Y. Wu, (unknown), (unknown), Robert J. Spinner, Jonathan J. Stone	0
7	Quantitative pharmacology of dual‐targeted bicistronic CAR‐T‐cell therapy using multiscale mechanistic modeling 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), (unknown), (unknown), (unknown), Aman P. Singh	2
8	Combination therapy with GalNAc-siRNA drugs targeting both PCSK9 and APOC3 resulted in enhanced lipid lowering in mice 2024 ·European Heart Journal ·Hai‐Bin Luo, Sihao Zheng, Hailong Cao, Aman P. Singh, Chao Tong, Hao Zhang, Liang Zhang, (unknown), Johan Wikström, Gao S, Li‐Ming Gan	0
9	Updated results from first-in-human phase 1 dose-escalation trial of TAK-102, a GPC3-targeted armored CAR T cells, in patients with advanced solid tumors. 2024 ·Journal of Clinical Oncology ·Takako Eguchi Nakajima, Yasutoshi Kuboki, Masaru Fukahori, Yutaka Shimazu, Shunsuke Kondo, Yuki Katsuya, Masafumi Ikeda, (unknown), (unknown), Takenori Akaike, Aman P. Singh, Kondala R. Atkuri, Petar Pop-Damkov, Koji Tamada, Takafumi Koyama	11
10	Development of minimal physiologically-based pharmacokinetic-pharmacodynamic models for characterizing cellular kinetics of CAR T cells following local deliveries in mice 2022 ·Journal of Pharmacokinetics and Pharmacodynamics ·Chia-Hung Dylan Tsai, Aman P. Singh, Cindy Q. Xia, Haiqing Wang	8
11	Development of a quantitative relationship between CAR-affinity, antigen abundance, tumor cell depletion and CAR-T cell expansion using a multiscale systems PK-PD model 2019 ·mAbs ·Aman P. Singh, Xirong Zheng, Xiefan Lin‐Schmidt, (unknown), Thomas Carpenter, (unknown), Weirong Wang, Donald Heald	84
12	Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade Rats 2018 ·Frontiers in Pharmacology ·Ly M. Nguyen, Aman P. Singh, Paweł Wiczling, Wojciech Krzyżański	6
13	Application of a PK-PD Modeling and Simulation-Based Strategy for Clinical Translation of Antibody-Drug Conjugates: a Case Study with Trastuzumab Emtansine (T-DM1) 2017 ·The AAPS Journal ·Aman P. Singh, Dhaval K. Shah	34
14	Quantitative characterization of in vitro bystander effect of antibody-drug conjugates 2016 ·Journal of Pharmacokinetics and Pharmacodynamics ·Aman P. Singh, Sharad Sharma, Dhaval K. Shah	100
15	Gastrointestinal localization of metronidazole by a lactobacilli-inspired tetramic acid motif improves treatment outcomes in the hamster model ofClostridium difficileinfection 2015 ·Journal of Antimicrobial Chemotherapy ·Philip Cherian, Xiaoqian Wu, Lei Yang, (unknown), Aman P. Singh, (unknown), Richard Lee, Julian G. Hurdle	29
16	Synthesis and evaluation of pretomanid (PA-824) oxazolidinone hybrids 2015 ·Bioorganic & Medicinal Chemistry Letters ·Rakesh Rakesh, David F. Bruhn, Michaël Scherman, Aman P. Singh, Lei Yang, Jiuyu Liu, Anne J. Lenaerts, Richard Lee	29
17	Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development 2015 ·Pharmaceutical Research ·Aman P. Singh, Young G. Shin, Dhaval K. Shah	45
18	Pentacyclic Nitrofurans with In Vivo Efficacy and Activity against Nonreplicating Mycobacterium tuberculosis 2014 ·PLoS ONE ·Rakesh Rakesh, David F. Bruhn, Michaël Scherman, Lisa K. Woolhiser, (unknown), Marcus M. Maddox, Aman P. Singh, Robin B. Lee, Julian G. Hurdle, Michael McNeil, Anne J. Lenaerts, Bernd Meibohm, Richard Lee	29
19	Quantitative Prediction of Human Pharmacokinetics for mAbs Exhibiting Target-Mediated Disposition 2014 ·The AAPS Journal ·Aman P. Singh, Wojciech Krzyżański, Steven W. Martin, Gregory L. Weber, Alison Betts, Alaa Ahmad, Anson K. Abraham, Anup Zutshi, (unknown), (unknown)	40
20	Testicular toxicity of win 18446 in the laboratory mouse 1995 ·Reproductive Toxicology ·Aman P. Singh, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact